<DOC>
	<DOCNO>NCT01431495</DOCNO>
	<brief_summary>This study aim demonstrate non-inferiority Pidogrel 速 compare Plavix 速 patient coronary disease : - Primary Outcome Measures : measure platelet reactivity VerifyNow assay 600 mg load dose last maintenance dose ( 75 mg ) . - Secondary Outcome Measures : Time first occurrence major cardio-vascular event ( MACE ) . - Safety Criteria : severe bleeding ( GUSTO scale ) .</brief_summary>
	<brief_title>Clinical Assessment Pidogrel速 Versus Plavix速 ( CAPP )</brief_title>
	<detailed_description>randomization patient group ( Plavix Pidogrel ) , measure platelet activity VerifyNow assay , 4 12 hour load dose 600mg last dose clopidogrel patient maintenance dose . The VerifyNow assay determine : - The PRU : -P2Y12 Reaction Units- - % Of platelet inhibition It consider low responder clopidogrel resistant patient PRU &gt; 235 % inhibition &lt; 15 % . Monitoring patient include study take place period 12 month , MACE notify date . MACE criterion : angina , myocardial infarction , coronary angioplasty , coronary artery bypass graft , stroke . Each hemorrhagic event notify classified accord GUSTO scale .</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Male female , Old ( e ) 20 year Patients hospitalize acute coronary syndrome ( Whatever T troponin ) Patients proven coronary candidate treatment clopidogrel ( receive load dose 600mg 2 hour treat 75mg / clopidogrel longer 7 day ) Patients unwilling . Patient participate another study . Patients cardiogenic shock Patient anti GpIIbIIIa stop less 72 hour test aggregability Patients schedule surgery less 6 month . Patients candidate coronary angioplasty Patients underwent TAC + / bare stent few 30 day . Patients underwent stenting ATC active less 12 month . ischemic stroke old 6 week . History hemorrhagic stroke ( time ) Patients warfarin candidate Patients different anti ADP ( ticlopidine , prasugrel ) Patients indication clopidogrelcons ( side effect , bleed ... ) Thrombocytopenia &lt; 100000/mm3 anemia ( Ht &lt; 30 % ) Thrombocythaemia ( Ht &gt; 52 % ) Patients seek treatment elective form Clopidogrel . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>platelet agregation</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>major adverse cardiac event ( MACE )</keyword>
</DOC>